RENASANT CORP 10-Q

Item 5. OTHER INFORMATION Trading Plans During the quarter ended March 31, 2025, no director or officer (as defined in Rule 16a-1(f) under the Securities Exchange Act of 1934, as amended) adopted or terminated any “Rule 10b5-1 trading arrangement” or “non-Rule 10b5-1 trading arrangement” (each as defined in Item 408(a) of Regulation S-K). Item 6. EXHIBITS Exhibit Number Description 2(i) Agreement and Plan of Merger by and between Renasant Corporation and The First Bancshares, In c. (1) (3)(i) Articles of Incorporation of Renasant Corporation, as amended (2) (3)(ii) Articles of Amendment to the Articles of Incorporation of Renasant Corporation (3) (3)(iii) Articles of Amendment to the Articles of Incorporation of Renasant Corp oration (4) (3)(iv) Amended and Restated Bylaws of Renasant Corporation ( 5 ) (31)(i) Certification of the Principal Executive Officer, as required pursuant to Section 302 of the Sarbanes-Oxley Act of 2002. (31)(ii) Certification of the Principal Financial Officer, as required pursuant to Section 302 of the Sarbanes-Oxley Act of 2002. (32)(i) Certification of the Principal Executive Officer, as required pursuant to Section 906 of the Sarbanes-Oxley Act of 2002. (32)(ii) Certification of the Principal Financial Officer, as required pursuant to Section 906 of the Sarbanes-Oxley Act of 2002. (101) The following materials from Renasant Corporation’s Quarterly Report on Form 10-Q for the quarter ended March 31, 2025 were formatted in Inline XBRL (eXtensible Business Reporting Language): (i) Consolidated Balance Sheets, (ii) Consolidated Statements of Income, (iii) Consolidated Statements of Comprehensive Income, (iv) Consolidated Statements of Changes in Shareholders’ Equity, (v) Consolidated Statements of Cash Flows and (vi) Notes to Consolidated Financial Statements (Unaudited). (104) The cover page of Renasant Corporation’s Quarterly Report on Form 10-Q for the quarter ended March 31, 2025, formatted in Inline XBRL (included in Exhibit 101). (1) Filed as exhibit 2(i) to the Form 8-K of the Company filed with the Securities and Exchange Commission (the “Commission”) on July 29, 2024, and incorporated herein by reference. The disclosure schedules and exhibits have been omitted pursuant to Item 601(a)(5) of Regulation S-K. A copy of any omitted schedule will be furnished supplementally to the Commission upon request; provided, however, that the Company may request confidential treatment pursuant to Rule 24b-2 of the Securities Exchange Act of 1934, as amended for any document so furnished. (2) Filed as exhibit 3.1 to the Form 10-Q of the Company filed with the Commission on May 10, 2016, and incorporated herein by reference. (3) Filed as exhibit 3(i) to the Form 8-K the Company filed with the Commission on April 25, 2024, and incorporated herein by reference. (4) Filed as Appendix B-1 and Appendix B-2 to the Company’s Definitive Proxy Statement for its 2025 Annual Meeting of Shareholders, filed with the Commission on March 12, 2025, and incorporated herein by reference. (5) Filed as exhibit 3(ii) to the Form 8-K of the Company filed with the Commission on October 24, 2024, and incorporated herein by reference. The Company does not have any long-term debt instruments under which securities are authorized exceeding ten percent of the total assets of the Company and its subsidiaries on a consolidated basis. The Company will furnish to the Commission, upon its request, a copy of all long-term debt instruments. 67 Table of Contents SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized. RENASANT CORPORATION (Registrant) Date: May 8, 2025 /s/ Kevin D. Chapman Kevin D. Chapman President and Chief Executive Officer (Principal Executive Officer) Date: May 8, 2025 /s/ James C. Mabry IV James C. Mabry IV Executive Vice President and Chief Financial Officer (Principal Financial Officer) 68